Insights

Recent IPO Kallyope Inc. recently went public, indicating potential growth and increased visibility in the market, creating an opportunity to engage with new investors and stakeholders.

New therapeutics launch With the launch of a G protein-coupled receptor (GPCR) target for GI diseases, Kallyope Inc. has introduced innovative solutions, presenting a chance to explore partnerships with healthcare providers and pharmaceutical companies in the GI health sector.

Strategic partnership funding Receiving a significant grant from the Bill & Melinda Gates Foundation for improving maternal and child health signals a commitment to impactful solutions, opening doors for collaborations with organizations focused on similar healthcare initiatives.

Expert scientific team Kallyope Inc. boasts a team of top scientific minds, including seasoned professionals like Franz Humer, enhancing credibility and expertise in the biotechnology field, positioning the company as a valuable collaborator for research and development projects.

Leadership promotions Key promotions within Kallyope Inc., such as the appointment of Shirly Pinto as Vice President and Head of Translational Medicine, indicate a focus on talent development and innovation, signaling opportunities to engage with emerging leaders and influencers within the organization.

Kallyope Tech Stack

Kallyope uses 8 technology products and services including Fastly, MySQL, Webpack, and more. Explore Kallyope's tech stack below.

  • Fastly
    Content Delivery Network
  • MySQL
    Database
  • Webpack
    Development
  • Python
    Programming Languages
  • JavaScript
    Programming Languages
  • Google
    Search Engines
  • Base SAS
    Software As A Service
  • EWWW Image Optimizer
    Web Platform Extensions

Media & News

Kallyope's Email Address Formats

Kallyope uses at least 1 format(s):
Kallyope Email FormatsExamplePercentage
First@kallyope.comJohn@kallyope.com
33%
First.Last@kallyope.comJohn.Doe@kallyope.com
17%
First@kallyope.comJohn@kallyope.com
33%
First.Last@kallyope.comJohn.Doe@kallyope.com
17%

Frequently Asked Questions

Where is Kallyope's headquarters located?

Minus sign iconPlus sign icon
Kallyope's main headquarters is located at 430 E. 29th Street New York, New York 10016 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Kallyope's phone number?

Minus sign iconPlus sign icon
You can contact Kallyope's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kallyope's official website and social media links?

Minus sign iconPlus sign icon
Kallyope's official website is kallyope.com and has social profiles on LinkedIn.

How much revenue does Kallyope generate?

Minus sign iconPlus sign icon
As of May 2025, Kallyope's annual revenue reached $35M.

What is Kallyope's SIC code NAICS code?

Minus sign iconPlus sign icon
Kallyope's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kallyope have currently?

Minus sign iconPlus sign icon
As of May 2025, Kallyope has approximately 70 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: S. P.Chief Financial Officer: P. E. F.Chief Medical Officer: B. L.. Explore Kallyope's employee directory with LeadIQ.

What industry does Kallyope belong to?

Minus sign iconPlus sign icon
Kallyope operates in the Biotechnology Research industry.

What technology does Kallyope use?

Minus sign iconPlus sign icon
Kallyope's tech stack includes FastlyMySQLWebpackPythonJavaScriptGoogleBase SASEWWW Image Optimizer.

What is Kallyope's email format?

Minus sign iconPlus sign icon
Kallyope's email format typically follows the pattern of . Find more Kallyope email formats with LeadIQ.

How much funding has Kallyope raised to date?

Minus sign iconPlus sign icon
As of May 2025, Kallyope has raised $8.2M in funding. The last funding round occurred on May 10, 2023 for $8.2M.

When was Kallyope founded?

Minus sign iconPlus sign icon
Kallyope was founded in 2015.
Kallyope

Kallyope

Biotechnology ResearchNew York, United States51-200 Employees

At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. 

Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease.

Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development.

Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.

Section iconCompany Overview

Headquarters
430 E. 29th Street New York, New York 10016 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $8.2M

    Kallyope has raised a total of $8.2M of funding over 6 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $8.2M.

  • $10M$50M

    Kallyope's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $8.2M

    Kallyope has raised a total of $8.2M of funding over 6 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $8.2M.

  • $10M$50M

    Kallyope's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.